Dan Miller works for GAMCO investors and the Gabelli funds, he manages 35 industry analysts. His talk is called “Investing with Conviction”, and he’s working with the Gabelli concept of “private market value” — they call it “PMV with a Catalyst” and he published a quarterly list of the “Focus Five” — the five most […]
Articles
There’s a small stack of potential teasers just sitting and waiting for the attention of the Thinkolator, but your friendly neighborhood Gumshoe is but a humble servant to the masses of the assembled Gumshoe faithful … so when I start getting hundreds of questions about one specific teaser, that moves to the top of the […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...
Thanks, I didn’t run across the Boston presentation....
SGMO has lost nearly half it's value since late Aug., 2018! What has the market done since then??? NEXT!!!...
If SGMO had anything worth pursuing they would have been bought out by now. Wait until they get approval and start makin...
SGMO is down 34% at 1:30 EST. Down more at 11:30, but seem to have risen a little....
It is Sangamo Therapeutics ( SGMO )....
The ONLY gene editing stock to own is SGMO. No off targets unlike the rest. 7 readouts this year. Imo, will cure HIV ...
Does anyone own Sangamo Therapeutics. (SGMO) I should call myself the "Greenhorn" because I know virtually nothing about...
Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...
SGMO down 20% today looks like things didn't go so well: https://www.marketwatch.com/story/sangamo-stock-drops-13-pre...
Good results but shares drop 20% good spot from Travis, on the opportunity to buy as it happens that would seem to be t...
Right, that's the dream of future possibility... but the first trial data is for a very small disease. Not unusual, jus...
Hi All , Sangamo are holding a conference call today just after the presentation in Greece, The call will follow the ...
https://www.fool.com/investing/2018/09/03/why-sangamo-therapeutics-shot-337-higher-in-august.aspx...
As usual - you got it right...:) Confirming its SGMO, recommended up to 20.00 or the SGMO Sept 2018 17 calls for 3 or ...
I own a few shares of SGMO, along with CRSP, EDIT, and NLT, and 16 other micro cap Biogen stocks, and I feel that this i...
NOVUS reported the following top five 2015 Q1 hedge fund stock-pickers in the Healthcare sector: RA Cap Management; BB...
Patents by Assignee Sangamo Biosciences, Inc. http://patents.justia.com/assignee/sangamo-biosciences-inc...
Long post alert. Mostly for Doc KSS. I remember Sangamo Biosciences ($SGMO) being discussed earlier w.r.t. BLUE. I was ...
Leo S - RE: Biotechnology Threads Focus- My point is Leo S Look at the BioTech equities that increased Thursday and Frid...
The following info about RA Capital's holdings, as at end of 2013 may be of interest to some of you: 37 Positions as of...
Hi Booya (maybe you are Cramer) re your reply on March 5th to the original post #10 dated 1/8/2014 on Sangamo Bioscience...
SGMO Trading at $23.75ish off a $19.61 close on the news below. Sangamo BioSciences announced the publication in t...
I own shares of Sangamo Biosciences (SGMO). Sangamo is focused on the research and commercial development of engineered ...